CKD Bio Corp.(KR:063160)
â‚©10,840.00+90.00 (+0.84%)
KR:063160
CKD Bio Corp. financials statements
â‚©10,840.00
At close:+90.00 (+0.84%)
Want to see KR:063160 full AI Analyst Report?
CKD Bio Corp. (063160) Ratios
CKD Bio Corp. Ratios
KR:063160's free cash flow for Q2 2026 was ₩-749.41M. For the 2026 fiscal year, KR:063160's free cash flow was decreased by ₩-3.37B and operating cash flow was ₩2.62B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.90 | 1.27 | 1.13 | 1.51 | 2.35 |
| Quick Ratio | 0.26 | 0.38 | 0.43 | 0.55 | 0.77 |
| Cash Ratio | 0.01 | 0.01 | 0.04 | 0.06 | 0.08 |
| Solvency Ratio | 0.07 | 0.17 | -0.04 | 0.01 | 0.08 |
| Operating Cash Flow Ratio | -0.03 | 0.15 | -0.07 | -0.04 | -0.13 |
| Short-Term Operating Cash Flow Coverage | -0.03 | 0.20 | -0.10 | -0.06 | -0.30 |
| Net Current Asset Value | â‚© -36.59B | â‚© -38.27B | â‚© -58.99B | â‚© -41.33B | â‚© -32.71B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.48 | 0.46 | 0.50 | 0.44 | 0.37 |
| Debt-to-Equity Ratio | 1.14 | 1.00 | 1.19 | 0.94 | 0.68 |
| Debt-to-Capital Ratio | 0.53 | 0.50 | 0.54 | 0.48 | 0.40 |
| Long-Term Debt-to-Capital Ratio | 0.12 | 0.31 | 0.36 | 0.35 | 0.36 |
| Financial Leverage Ratio | 2.36 | 2.17 | 2.39 | 2.11 | 1.85 |
| Debt Service Coverage Ratio | 0.15 | 0.41 | -0.02 | 0.07 | 0.58 |
| Interest Coverage Ratio | 0.64 | 2.08 | -4.04 | -5.03 | -5.07 |
| Debt to Market Cap | 1.28 | 1.08 | 1.09 | 1.04 | 0.47 |
| Interest Debt Per Share | 27432.79 | 24876.74 | 27691.65 | 25859.41 | 20290.86 |
| Net Debt to EBITDA | 7.45 | 4.17 | -87.89 | 58.72 | 19.04 |
| Profitability Margins | |||||
| Gross Profit Margin | 16.31% | 20.93% | 3.12% | 10.76% | 9.35% |
| EBIT Margin | 2.25% | 8.43% | -11.98% | -10.03% | -8.03% |
| EBITDA Margin | 12.03% | 18.15% | -1.02% | 1.47% | 3.91% |
| Operating Profit Margin | 2.25% | 6.38% | -12.57% | -9.47% | -6.90% |
| Pretax Profit Margin | -1.85% | 5.37% | -15.09% | -11.91% | -9.39% |
| Net Profit Margin | -1.80% | 5.07% | -15.09% | -10.70% | -4.62% |
| Continuous Operations Profit Margin | -1.80% | 5.07% | -15.09% | -10.70% | -4.62% |
| Net Income Per EBT | 97.36% | 94.41% | 99.98% | 89.85% | 49.23% |
| EBT Per EBIT | -82.29% | 84.14% | 120.07% | 125.86% | 136.16% |
| Return on Assets (ROA) | -0.96% | 3.06% | -8.23% | -5.34% | -2.20% |
| Return on Equity (ROE) | -2.27% | 6.64% | -19.66% | -11.30% | -4.07% |
| Return on Capital Employed (ROCE) | 2.44% | 5.65% | -10.33% | -6.39% | -3.86% |
| Return on Invested Capital (ROIC) | 1.28% | 3.91% | -7.42% | -4.61% | -1.76% |
| Return on Tangible Assets | -0.98% | 3.13% | -8.41% | -5.41% | -2.22% |
| Earnings Yield | -2.59% | 7.21% | -18.22% | -12.77% | -2.87% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.33 | 5.49 | 2606.43 | 5.68 | 4.75 |
| Payables Turnover | 21.94 | 22.73 | 23.24 | 16.92 | 12.96 |
| Inventory Turnover | 1.38 | 1.69 | 2.25 | 1.77 | 1.83 |
| Fixed Asset Turnover | 1.03 | 1.08 | 0.93 | 0.86 | 0.74 |
| Asset Turnover | 0.53 | 0.60 | 0.55 | 0.50 | 0.48 |
| Working Capital Turnover Ratio | 36.68 | 9.12 | 5.83 | 3.06 | 2.78 |
| Cash Conversion Cycle | 331.39 | 266.93 | 146.75 | 248.47 | 247.80 |
| Days of Sales Outstanding | 84.39 | 66.52 | 0.14 | 64.27 | 76.79 |
| Days of Inventory Outstanding | 263.64 | 216.47 | 162.32 | 205.78 | 199.17 |
| Days of Payables Outstanding | 16.64 | 16.06 | 15.71 | 21.58 | 28.16 |
| Operating Cycle | 348.03 | 282.98 | 162.46 | 270.05 | 275.96 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -754.78 | 2557.62 | -1316.79 | -584.14 | -1072.22 |
| Free Cash Flow Per Share | -1994.58 | 1777.00 | -3281.52 | -1902.09 | -4846.52 |
| Dividend Paid and CapEx Coverage Ratio | -0.56 | 2.90 | -0.67 | -0.41 | -0.27 |
| Capital Expenditure Coverage Ratio | -0.61 | 3.28 | -0.67 | -0.44 | -0.28 |
| Operating Cash Flow Coverage Ratio | -0.03 | 0.11 | -0.05 | -0.02 | -0.05 |
| Operating Cash Flow to Sales Ratio | -0.03 | 0.08 | -0.05 | -0.02 | -0.04 |
| Free Cash Flow Yield | -9.80% | 8.08% | -13.56% | -7.98% | -11.59% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -38.68 | 13.87 | -5.49 | -7.83 | -34.87 |
| Price-to-Sales (P/S) Ratio | 0.70 | 0.70 | 0.83 | 0.84 | 1.61 |
| Price-to-Book (P/B) Ratio | 0.88 | 0.92 | 1.08 | 0.89 | 1.42 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -10.20 | 12.38 | -7.37 | -12.54 | -8.62 |
| Price-to-Operating Cash Flow Ratio | -26.96 | 8.60 | -18.38 | -40.83 | -38.98 |
| Price-to-Earnings Growth (PEG) Ratio | 0.29 | -0.10 | -0.12 | -0.05 | 0.17 |
| Enterprise Value Multiple | 13.25 | 8.05 | -169.31 | 115.93 | 60.27 |
| Enterprise Value | 255.23B | 250.80B | 276.06B | 265.11B | 335.23B |
| EV to EBITDA | 13.25 | 8.05 | -169.31 | 115.93 | 60.27 |
| EV to Sales | 1.59 | 1.46 | 1.72 | 1.70 | 2.36 |
| EV to Free Cash Flow | -23.31 | 25.73 | -15.33 | -25.41 | -12.61 |
| EV to Operating Cash Flow | -61.61 | 17.87 | -38.21 | -82.73 | -56.99 |
| Tangible Book Value Per Share | 22126.19 | 22704.07 | 21306.55 | 26241.61 | 28931.74 |
| Shareholders’ Equity Per Share | 23143.67 | 23880.63 | 22425.33 | 26941.40 | 29437.20 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.03 | 0.06 | 0.00 | 0.10 | 0.51 |
| Revenue Per Share | 29162.14 | 31308.06 | 29229.67 | 28443.94 | 25927.71 |
| Net Income Per Share | -526.21 | 1586.01 | -4409.90 | -3044.61 | -1198.81 |
| Tax Burden | 0.97 | 0.94 | 1.00 | 0.90 | 0.49 |
| Interest Burden | -0.82 | 0.64 | 1.26 | 1.19 | 1.17 |
| Research & Development to Revenue | 0.02 | 0.08 | 0.08 | 0.10 | 0.08 |
| SG&A to Revenue | 0.04 | 0.03 | 0.08 | 0.06 | 0.05 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.43 | 1.61 | 0.30 | 0.19 | 0.89 |
Currency in KRW

